Destiny Pharma is dedicated to the development of novel anti-infectives that prevent infection and improve outcomes for patients.”


Our vision is of an expanding range of new antimicrobial drug products with unique features that can access hospital markets that are closed to traditional or new antibiotics due to the threat of antibiotic resistance, generic competition and pricing challenges.

Destiny’s proprietary XF drug platform acts via an ultra-rapid action that kills targeted bacteria (including antibiotic resistant strains) leaving the bacteria unable to mount a resistance.